Abaris Biotech.Opportunities A USD/ LU2210105313 /
| NAV21/05/2024 | Diferencia+0.0300 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 62.5500USD | +0.05% | reinvestment | Equity Worldwide | Hauck & Aufhäuser ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | 6.95 | -1.98 | -12.28 | 4.77 | -8.19 | 6.42 | -8.04 | 3.78 | -5.47 | 1.72 | -15.13 | 0.42 | -26.38% |
| 2022 | -25.72 | 3.45 | 3.48 | -20.26 | -16.00 | 6.47 | 11.18 | 0.90 | -6.68 | -0.79 | -5.98 | 1.78 | -43.64% |
| 2023 | 15.67 | -7.95 | -9.99 | 4.17 | 4.20 | -1.41 | 3.73 | -8.69 | -10.28 | -17.12 | 22.41 | 32.47 | +17.13% |
| 2024 | -1.75 | 38.41 | -6.39 | -13.54 | 6.02 | - | - | - | - | - | - | - | - |
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 42.45% | 43.78% | 39.46% | 42.34% | -% |
| Índice de Sharpe | 1.08 | 3.47 | 0.70 | -0.41 | - |
| El mes mejor | +38.41% | +38.41% | +38.41% | +38.41% | - |
| El mes peor | -13.54% | -13.54% | -17.12% | -25.72% | - |
| Pérdida máxima | -22.94% | -22.94% | -37.40% | -69.48% | - |
| Rendimiento superior | -12.71% | - | - | - | - |
Todas las cotizaciones en USD
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Abaris Biotech.Opportunities A C... | reinvestment | 62.7300 | +32.04% | -34.93% | |
| Abaris Biotech.Opportunities A E... | reinvestment | 68.6500 | +30.49% | -26.91% | |
| Abaris Biotech.Opportunities A U... | reinvestment | 62.5500 | +31.27% | -35.21% |
Performance
| Año hasta la fecha | +16.68% | ||
|---|---|---|---|
| 6 Meses | +59.36% | ||
| Promedio móvil | +31.27% | ||
| 3 Años | -35.21% | ||
| 5 Años | - | ||
| 10 Años | - | ||
| Desde el principio | -43.51% | ||
| Año | |||
| 2023 | +17.13% | ||
| 2022 | -43.64% | ||
| 2021 | -26.38% | ||
